|
RB1CC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07890396406196E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51069999843045E-08 |
| Normal-vs-Stage2 |
2.3543999999931E-05 |
| Normal-vs-Stage3 |
9.20549969585238E-10 |
| Normal-vs-Stage4 |
2.8740999580279E-09 |
| Stage1-vs-Stage2 |
9.212600E-01 |
| Stage1-vs-Stage3 |
9.550200E-02 |
| Stage1-vs-Stage4 |
2.631900E-02 |
| Stage2-vs-Stage3 |
2.880800E-01 |
| Stage2-vs-Stage4 |
1.291640E-01 |
| Stage3-vs-Stage4 |
5.615600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55609969354487E-10 |
| Normal-vs-AfricanAmerican |
6.577200E-04 |
| Normal-vs-Asian |
2.46559999994567E-06 |
| Caucasian-vs-AfricanAmerican |
7.446000E-01 |
| Caucasian-vs-Asian |
9.333800E-01 |
| AfricanAmerican-vs-Asian |
8.095200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09400000170012E-09 |
| Normal-vs-Female |
6.13890049905308E-10 |
| Male-vs-Female |
4.439200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.34630000003799E-06 |
| Normal-vs-Age(41-60Yrs) |
5.60269608484987E-11 |
| Normal-vs-Age(61-80Yrs) |
2.54040000147171E-09 |
| Normal-vs-Age(81-100Yrs) |
5.242400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.955800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.515500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.464200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.922400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.842400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.846600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.341170E-01 |
| Classical-VS-Follicular |
8.016300E-02 |
| Classical-VS-Other |
2.901400E-01 |
| Classical-VS-Normal |
1.68189999705248E-08 |
| Tall-VS-Follicular |
7.596600E-01 |
| Tall-VS-Other |
7.628600E-01 |
| Tall-VS-Normal |
2.97609999999615E-06 |
| Follicular-VS-Other |
6.659800E-01 |
| Follicular-VS-Normal |
3.82979999935529E-08 |
| Other-VS-Normal |
5.077800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12109996233778E-10 |
| Normal-vs-N1 |
2.79490000032467E-07 |
| N0-vs-N1 |
8.456000E-01 |
|
|
